Omnicell Announces XT AmplifyBusiness Wire • 14 days ago
Omnicell, Inc. (Nasdaq:OMCL) (Omnicell or the Company), a leader in transforming the pharmacy care delivery model, today announced XT Amplify, a multi-year innovation program that is intended to...
Share to Feed
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will release its financial results for the first quarter 2024, before market open on Thursday, May 2, 2024...
Investors eyeing a purchase of Omnicell Inc (OMCL) stock, but tentative about paying the going market price of 27.53/share, might benefit from considering selling puts among the alternative...
Vanguard Group Inc. grew its position in shares of Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 15.1% during the third quarter, according to the company in its most recent disclosure with the...
Shares of Omnicell, Inc. (NASDAQ:OMCL Get Free Report) have received an average recommendation of Hold from the six brokerages that are currently covering the stock, MarketBeat...
Pacer Advisors Inc. raised its stake in shares of Omnicell, Inc. (NASDAQ:OMCL Free Report) by 321,488.8% during the 4th quarter, according to its most recent filing with the Securities and...
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, will present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum on Wednesday, March 20, 2024...
Teza Capital Management LLC purchased a new position in shares of Omnicell, Inc. (NASDAQ:OMCL Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the...
Omnicell, Inc. (NASDAQ:OMCL Get Free Report) has been given an average rating of Hold by the six research firms that are currently covering the stock, MarketBeat Ratings...
This is a Bullish indicator signaling OMCL's price could rise from here. Traders may explore going long the stock or buying call options...